63E vs PHARM: Side-by-Side Comparison
Compare ONWARD MEDICAL BV EO -12 (63E) and Pharming Group NV (PHARM) side by side: market cap EUR 174.52M vs EUR 829.85M. Financials, growth and model signals on Bullrun.
| Metric | 63E | PHARM |
|---|---|---|
| Company | ONWARD MEDICAL BV EO -12 | Pharming Group NV |
| Country / Exchange | Netherlands · F | Netherlands · AS |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | EUR 174.52M | EUR 829.85M |
| P/E ratio | — | 83.0 |
| Dividend yield | — | — |
| Valuation model | — | 48.1% overvalued |
| Revenue (FY2025) | EUR 3.78M | USD 376.13M |
| Revenue growth YoY | +1550.7% | +26.6% |
| Net income | EUR -41.79M | USD 2.54M |
| Gross margin | 72.5% | 87.9% |
| Diluted EPS | -0.90 | 0.00 |
Figures are in each company's reporting currency — compare growth rates and margins rather than raw amounts.